- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (198)
- Timeline of Article Publication (6)
- Authors Evaluation (5)
- Article Quality Tracking (0)
- Reference Citation Analysis (4)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3265)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2024 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Buddhavarapu V, Dhillon G, Grewal H, Sharma P, Kashyap R, Surani S. Safety of teplizumab in patients with high-risk for diabetes mellitus type 1: A systematic review. World J Diabetes 2024; 15(8): 1793-1801 [PMID: 39192866 DOI: 10.4239/wjd.v15.i8.1793] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i8/1793.htm |
| Number | Citing Articles |
| 1 |
Maria Aurora Roma-Wilson, Pozzilli Paolo. What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?. Journal of Diabetes and its Complications 2025; : 109132 doi: 10.1016/j.jdiacomp.2025.109132
|
| 2 |
Ana M. Wägner, Marta Hernández García. Estado de la prevención de la diabetes mellitus tipo 1: promesas y realidades. Endocrinología, Diabetes y Nutrición 2025; 72(1): 1 doi: 10.1016/j.endinu.2024.10.002
|
| 3 |
Ana M. Wägner, Marta Hernández García. Status of type 1 diabetes mellitus prevention: promises and realities. Endocrinología, Diabetes y Nutrición (English ed.) 2025; 72(1): 1 doi: 10.1016/j.endien.2024.12.004
|
| 4 |
Ha Rim Yang, Ji Woong Kim, Hye Lim Choi, Hyunbo Shim, Sukmook Lee. Development of a novel CD3ε-specific human antibody for selective modulation of T cell activation. International Journal of Biological Macromolecules 2025; 320: 145859 doi: 10.1016/j.ijbiomac.2025.145859
|